Mayne Pharma Group (Mayne Pharma Group) Days Sales Outstanding : 181.34 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Mayne Pharma Group Days Sales Outstanding?

Mayne Pharma Group's average Accounts Receivable for the six months ended in Dec. 2023 was $124.5 Mil. Mayne Pharma Group's Revenue for the six months ended in Dec. 2023 was $125.3 Mil. Hence, Mayne Pharma Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 181.34.

The historical rank and industry rank for Mayne Pharma Group's Days Sales Outstanding or its related term are showing as below:

MAYNF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.68 Med: 167.03 Max: 447.12
Current: 279.69

During the past 13 years, Mayne Pharma Group's highest Days Sales Outstanding was 447.12. The lowest was 67.68. And the median was 167.03.

MAYNF's Days Sales Outstanding is ranked worse than
96.5% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.45 vs MAYNF: 279.69

Mayne Pharma Group's Days Sales Outstanding declined from Dec. 2022 (469.29) to Dec. 2023 (181.34).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Mayne Pharma Group Days Sales Outstanding Historical Data

The historical data trend for Mayne Pharma Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Days Sales Outstanding Chart

Mayne Pharma Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

182.53

178.21

158.56

193.41

459.37

Mayne Pharma Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															182.62	188.47	469.29	485.45	181.34

Competitive Comparison of Mayne Pharma Group's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mayne Pharma Group's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's Days Sales Outstanding falls into.

Mayne Pharma Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Mayne Pharma Group's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (182.732	+	125.383)	/	2 )	/	122.409	*	365
=	154.0575					/	122.409	*	365
=	459.37

Mayne Pharma Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (125.383	+	123.616)	/	2 )	/	125.297	*	365 / 2
=	124.4995					/	125.297	*	365 / 2
=	181.34

Mayne Pharma Group (OTCPK:MAYNF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Mayne Pharma Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group (Mayne Pharma Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (OTCPK:MAYNF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

HG6:Germany MYX:Australia

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women's health products in the US. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.